Radar Telegram alerts Open Radar

Ginzburg told about the condition of the first patient who received the vaccine in oncological metastases from the first patient who received the oncological vaccine, left, and after four months of observation, he had no neoplasms, said Alexander Ginzburg, scientific director of the Gamalei National Research Center. "The first patient finished the treatment: he has a metabolism, and for four months he is fine," he said. According to the academician, the patient is monitored every month for three years. The head of the National Institute of Radiology Andrei Kaprin turns it into a detailed high-resolution CT scan, first of all, to examine the lymph nodes. Ginzburg explained the principle of MRNA vaccination: it tunes the immune system so that it destroys the tumor and metastases. For each patient, an individual medicine is created based on their genetic data. In April, the NMIC radiology patient with melanoma for the first time had such a vaccine "Neoonkovak". The project was implemented in collaboration with Gancaba NICEM.

תרגם לעברית

The Еxpert · · Source

Ginzburg told about the condition of the first patient who received the vaccine in oncological metastases from the first patient who received the oncological vaccine, left, and after four months of observation, he had no neoplasms, said Alexander Ginzburg, scientific director of the Gamalei National Research Center. "The first patient finished the treatment: he has a metabolism, and for four months he is fine," he said. According to the academician, the patient is monitored every month for three years. The head of the National Institute of Radiology Andrei Kaprin turns it into a detailed high-resolution CT scan, first of all, to examine the lymph nodes. Ginzburg explained the principle of MRNA vaccination: it tunes the immune system so that it destroys the tumor and metastases. For each patient, an individual medicine is created based on their genetic data. In April, the NMIC radiology patient with melanoma for the first time had such a vaccine "Neoonkovak". The project was implemented in collaboration with Gancaba NICEM.

Ginzburg told about the condition of the first patient who received the vaccine in oncological metastases from the first patient who received the oncological vaccine, left, and after four months of observation, he had no neoplasms, said Alexander Ginzburg, scientific director of the Gamalei National Research Center. "The first patient finished the treatment: he has a metabolism, and for four months he is fine," he said. According to the academician, the patient is monitored every month for three years. The head of the National Institute of Radiology Andrei Kaprin turns it into a detailed high-resolution CT scan, first of all, to examine the lymph nodes. Ginzburg explained the principle of MRNA vaccination: it tunes the immune system so that it destroys the tumor and metastases. For each patient, an individual medicine is created based on their genetic data. In April, the NMIC radiology patient with melanoma for the first time had such a vaccine "Neoonkovak". The project was implemented in collaboration with Gancaba NICEM.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram